» Articles » PMID: 29908918

The Critical Importance of Retention in HIV Prevention

Overview
Journal Lancet HIV
Date 2018 Jun 18
PMID 29908918
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Adapting mHealth Interventions (PrEPmate and DOT Diary) to Support PrEP Retention in Care and Adherence Among English and Spanish-Speaking Men Who Have Sex With Men and Transgender Women in the United States: Formative Work and Pilot Randomized Trial.

Liu A, Alleyne C, Doblecki-Lewis S, Koester K, Gonzalez R, Vinson J JMIR Form Res. 2024; 8:e54073.

PMID: 38536232 PMC: 11007601. DOI: 10.2196/54073.


Assessing the Preliminary Efficacy of a Nonrandomized, Clinic-Based HIV Risk Reduction Pilot Intervention for PrEP-Initiated, Alcohol- and Other Drug-Using Women of Color in Miami, FL.

Ichite A, Jean-Gilles M, Rosenberg R, Abbamonte J, Devieux J J Racial Ethn Health Disparities. 2023; 10(6):3077-3094.

PMID: 36648620 PMC: 10645637. DOI: 10.1007/s40615-022-01482-5.


Loss to Follow-Up from HIV Pre-Exposure Prophylaxis Care in Men Who Have Sex with Men in West Africa.

Eubanks A, Coulibaly B, Keita B, Anoma C, Dah T, Mensah E Viruses. 2022; 14(11).

PMID: 36366478 PMC: 9695325. DOI: 10.3390/v14112380.


Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action.

Golub S, Fikslin R J Int AIDS Soc. 2022; 25 Suppl 1:e25930.

PMID: 35818865 PMC: 9274207. DOI: 10.1002/jia2.25930.


Factors associated with PrEP adherence among MSM living in Jackson, Mississippi.

Whiteley L, Craker L, Sun S, Tarantino N, Hershkowitz D, Moskowitz J J HIV AIDS Soc Serv. 2022; 20(3):246-261.

PMID: 35662802 PMC: 9162088. DOI: 10.1080/15381501.2021.1956666.


References
1.
Shapiro M, Morton S, McCaffrey D, Senterfitt J, Fleishman J, Perlman J . Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999; 281(24):2305-15. DOI: 10.1001/jama.281.24.2305. View

2.
Chan P, Mena L, Patel R, Oldenburg C, Beauchamps L, Perez-Brumer A . Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016; 19(1):20903. PMC: 4908080. DOI: 10.7448/IAS.19.1.20903. View

3.
Rusie L, Orengo C, Burrell D, Ramachandran A, Houlberg M, Keglovitz K . Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012-2017: Are Quarterly Visits Too Much?. Clin Infect Dis. 2018; 67(2):283-287. PMC: 7190936. DOI: 10.1093/cid/ciy160. View

4.
Golub S, Gamarel K, Rendina H, Surace A, Lelutiu-Weinberger C . From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013; 27(4):248-54. PMC: 3624632. DOI: 10.1089/apc.2012.0419. View

5.
Adams L, Balderson B . HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016; 28(9):1154-8. PMC: 4974057. DOI: 10.1080/09540121.2016.1153595. View